Delivery Order SPE2DB22D1017-SPE2DB25FF4KC

Award Date 1/30/25
Potential Completion Date 1/31/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 90-count packages of Alfuzosin HCL ER 10 mg tablets, a medication used to treat enlarged prostate, at a ceiling value of $20,091.92. This contract was awarded as a delivery order, with a firm fixed price, and does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.97 firm fixed-price delivery order is for the supply of Alfuzosin HCl ER 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,786.17 firm fixed-price delivery order is for the supply of 120 tablets of Alfuzosin HCL ER 10 mg, a medication used to treat the symptoms of an enlarged prostate. The contract has an ultimate completion date of July 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,584.96 firm fixed-price delivery order is for the supply of 90-tablet bottles of Alfuzosin HCL ER 10 mg, a medication used to treat enlarged prostate. The contract has an ultimate completion date of September 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,626.79, is for the delivery of 120 tablets of Alfuzosin HCl ER 10 mg, a medication used to treat the symptoms of an enlarged prostate. The contract has a completion date of March 6, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,663.29 firm fixed price delivery order is for 90 tablets of Alfuzosin HCl ER 10 mg, a medication used to treat benign prostatic hyperplasia. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,018.77, is for the delivery of Alfuzosin HCL ER 10 mg tablets. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,790.16, is for the delivery of Alfuzosin HCL ER 10 mg tablets, a medication used to treat symptoms of an enlarged prostate. The contract has a firm fixed price and runs through March 13, 2025. It is not designated as a set-aside contract. AmerisourceBergen also holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,063.19, is for the delivery of Alfuzosin ER 10 mg tablets, a medication used to treat an enlarged prostate. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 3, 2025. The contract is not designated as a set-aside....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical is for the provision of a wide range of pharmaceutical products and medical supplies to support the Department of Defense (DoD) globally. The contract, identified as SPE2DX15D7067|SPE2DX24F2ZVN, has a ceiling value of $3,805.62 and a completion date of July 9, 2024. The order is for 4,565,082,534 units of Alfuzosin HCL ER 10 mg tablets, a medication...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF4KC
    Delivery Order

This federal contract award, valued at $17,416.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alfuzosin HCL ER 10 mg tablets, a medication primarily used to treat symptoms of an enlarged prostate.

The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

In addition to the DLA contract, Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/21/25, 10:28 AM